Belief BioMed Celebrates FDA IND Acceptance for AskBio's Gene Therapy Aimed at Pompe Disease Treatment Belief BioMed proudly announces AskBio's FDA IND acceptance for AB-1009, a gene therapy for late-onset Pompe disease, marking a vital milestone.

Belief BioMed Celebrates FDA IND Acceptance for AskBio's Gene Therapy Aimed at Pompe Disease Treatment #Shanghai #USA #gene_therapy #Belief_BioMed #AskBio